PharmaVault
گنجینه اطلاعات داروسازی
The Pharmaceutical Information Vault
Excipient monograph · مونوگراف ماده جانبی
pharmavault.ir
Sodium starch glycolate
سدیم استارچ گلیکولات
1Nonproprietary names
- BPSodium Starch Glycolate
- Ph. Eur.Sodium Starch Glycolate
- USP–NFSodium Starch Glycolate
2Synonyms and trade names
Carboxymethyl starch, sodium salt; carboxymethylamylum natricum; Explotab; Glycolys; Primojel; sodium carboxymethyl starch; Vivastar P
3Chemical name and CAS Registry Number
Sodium carboxymethyl ether of starch, usually cross-linked (prepared mainly from potato starch) · [9063-38-1]
4Empirical formula and molecular weight
Polymer, mixture or material of variable composition — no single molecular formula applies.
5Functional category
Disintegrant
Typical concentrations: 2–8% · Dosage forms: Solid
6Applications in pharmaceutical formulation
Sodium starch glycolate is a 'superdisintegrant' used in oral tablets and capsules prepared by direct compression or wet granulation. Usual concentrations are 2–8% w/w, with about 4% often optimal; higher levels can slow disintegration because the swollen gel blocks further water uptake. It may be added intragranularly, extragranularly or split between the two.
7Description
A white or almost white, odourless, tasteless, free-flowing, very hygroscopic powder made up of oval or spherical granules. The pharmacopoeias describe types that differ in pH and sodium content (Ph. Eur. Types A, B and C; USP–NF Types A and B).
8Typical properties
- pH
- Type A 5.5–7.5; Type B 3.0–5.0 (aqueous dispersion)
- Sodium content
- Type A 2.8–4.2%; Type B 2.0–3.4% (dried basis)
- Loss on drying
- not more than 10% w/w
- Swelling
- swells rapidly in water to many times its original volume (up to about 300-fold) without dissolving
- Solubility
- practically insoluble in water and in most organic solvents; forms a translucent suspension in water
9Stability and storage conditions
Stable, but very hygroscopic. Store in a well-closed container to protect it from wide variations in humidity and temperature, which can cause caking. Tablets containing it may harden on storage at high humidity.
10Incompatibilities
Incompatible with ascorbic acid. Its disintegrant efficiency can be reduced by high concentrations of hydrophobic lubricants, by some highly soluble or hygroscopic excipients, and by high compression forces. As an anionic polymer it may bind some cationic drugs.
11Method of manufacture
Starch (usually potato starch) is cross-linked, either chemically (for example with sodium trimetaphosphate) or by dehydration, and then carboxymethylated by reaction with sodium monochloroacetate in an alkaline alcoholic medium. The product is neutralised with an acid such as citric acid, washed with aqueous alcohol to remove sodium chloride and glycolate by-products, and dried.
12Safety
Widely used in oral products and generally regarded as non-toxic and non-irritant. Very large oral amounts may be harmful, but such quantities are far above those used in formulations.
13Handling precautions
Observe normal precautions for the quantity handled. Avoid dust generation; eye protection, gloves and a dust mask are recommended.
14Regulatory status
Included in the FDA Inactive Ingredient Database (oral capsules and tablets) and in non-parenteral medicines licensed in Europe.
15Related substances
Croscarmellose sodium; crospovidone; pregelatinised starch; starch.
16Comments
Its rapid swelling with little gel formation makes it effective at low levels, but performance varies with degree of substitution, cross-linking and particle size, so the source and grade should be specified. It is less affected by wet granulation than many disintegrants, though some loss of efficiency can occur.